Analysen von Michael Leuchten
28.03.19 | Bayer buy | UBS AG | |
15.03.19 | Merck Neutral | UBS AG | |
07.03.19 | Merck buy | UBS AG | |
27.02.19 | Bayer buy | UBS AG | |
22.02.19 | Bayer buy | UBS AG | |
20.02.19 | Sartorius vz. Neutral | UBS AG | |
12.02.19 | Bayer buy | UBS AG | |
07.02.19 | GSK buy | UBS AG | |
Werbung
|
|||
30.01.19 | Novartis Neutral | UBS AG | |
29.01.19 | Sartorius vz. buy | UBS AG | |
18.01.19 | Novartis Neutral | UBS AG | |
02.01.19 | GSK buy | UBS AG | |
13.12.18 | Sartorius vz. buy | UBS AG | |
06.12.18 | Bayer buy | UBS AG | |
04.12.18 | GSK buy | UBS AG | |
30.11.18 | Novo Nordisk buy | UBS AG | |
26.11.18 | Novo Nordisk buy | UBS AG | |
21.11.18 | Novartis Neutral | UBS AG | |
13.11.18 | Bayer buy | UBS AG | |
05.11.18 | Novo Nordisk buy | UBS AG | |
01.11.18 | Novo Nordisk buy | UBS AG | |
01.11.18 | GSK buy | UBS AG | |
23.10.18 | Sartorius vz. Neutral | UBS AG | |
23.10.18 | Bayer buy | UBS AG | |
17.10.18 | Merck buy | UBS AG | |
11.10.18 | Bayer buy | UBS AG | |
10.10.18 | Novo Nordisk buy | UBS AG | |
05.10.18 | Novo Nordisk buy | UBS AG | |
27.09.18 | GSK buy | UBS AG | |
25.09.18 | Novartis Neutral | UBS AG | |
18.09.18 | Bayer buy | UBS AG | |
11.09.18 | Novartis Neutral | UBS AG | |
05.09.18 | Bayer buy | UBS AG | |
30.08.18 | Bayer buy | UBS AG | |
17.08.18 | Bayer buy | UBS AG | |
09.08.18 | Merck buy | UBS AG | |
08.08.18 | Novo Nordisk buy | UBS AG | |
03.08.18 | GSK buy | UBS AG | |
30.07.18 | GSK buy | UBS AG | |
26.07.18 | GSK buy | UBS AG | |
25.07.18 | Novo Nordisk buy | UBS AG | |
25.07.18 | GSK buy | UBS AG | |
23.07.18 | GSK buy | UBS AG | |
20.07.18 | Novartis Neutral | UBS AG | |
19.07.18 | Novartis Neutral | UBS AG | |
02.07.18 | Novartis Neutral | UBS AG | |
02.07.18 | GSK buy | UBS AG | |
26.06.18 | Bayer buy | UBS AG | |
26.06.18 | Merck buy | UBS AG | |
25.06.18 | Novo Nordisk buy | UBS AG |